[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BikeRieder BikeRieder🇨🇭
BikeRieder🇨🇭 posts on X about $arwr, future, frame, investment the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXXXX +57%
- X Month XXXXXX +191%
- X Months XXXXXX +78%
- X Year XXXXXXX +232%
Mentions: X #
- X Week XX no change
- X Month XX +38%
- X Months XX no change
- X Year XXX +213%
Followers: XXXXX #
- X Week XXXXX +0.16%
- X Month XXXXX +3.20%
- X Months XXXXX +7.20%
- X Year XXXXX +11%
CreatorRank: XXXXXXXXX #
Social Influence
Social category influence finance XXXX% stocks XXXX%
Social topic influence $arwr #3, future 9.09%, frame 9.09%, investment 9.09%, novartis XXXX%
Top accounts mentioned or mentioned by @hall8jack @lsinnv @truthtracer @superduperdrugs @rnaianalyst @valuedig @wkissel @drfager @trialradar @biomedicalrx @tadmakowiecki @cmac_lax_atx
Top assets mentioned Arrowhead Research Corporation (ARWR) Novartis AG (NVS)
Top Social Posts
Top posts by engagements in the last XX hours
"$ARWR Started investing in 2007 (pic). Now XX years later (pic) at the age of XX I wait for our first drug approval - of many to come in the future As you can see biotech investments can make you much older in a short time frame but also much richer"
X Link 2025-11-17T19:53Z 1862 followers, 21.1K engagements
"$ARWR Questions about the winner PlozaSiran versus Olezarsen NO"
X Link 2025-12-05T21:21Z 1864 followers, 1017 engagements
"$ARWR TRiMTM platform for subcutaneous delivery of siRNA to Central Nervous System. We could get some new data at next week's 7th Annual CNS Delivery Summit Dec XX 2025"
X Link 2025-12-07T08:18Z 1864 followers, 2325 engagements
"$ARWR New corporate presentation available. Highlights: 🎯919 million cash not incl. $XXX million from SRPT and another $XXX million from Novartis coming in the next X months. 🎯TRiM - broadest and most versatile in RNAi field 🎯Delivering X cell types 🎯19 drug candidates 🎯🎯REDEMPLO label - NO contraindications NO warnings or precautions No adverse event profile 🎯very big market opportunities with REDEMPLO starting 2026/2027"
X Link 2025-12-10T10:46Z 1864 followers, XXX engagements
"@Hall8Jack @LSinnv $ARWR"
X Link 2025-12-07T21:46Z 1863 followers, XXX engagements